| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | BIOMARIN PHARMACEUTICAL INC | 492,100 | 40,766,000 | 4.52% | ||
| 52 | CELGENE CORP | 433,981 | 50,233,000 | 5.56% | ||
| 53 | LILLY ELI & CO | 729,117 | 53,627,000 | 5.94% | ||
| 54 | PFIZER INC | 1,764,343 | 57,306,000 | 6.35% | ||
| 55 | MERCK & CO INC | 973,832 | 57,329,000 | 6.35% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-17-008034, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
